Biliary atresia: 50 years after the first kasai

Barbara E Wildhaber1

  • 1Division of Pediatric Surgery, Department of Pediatrics, University Hospital of Geneva, 1211 Geneva, Switzerland.

ISRN Surgery
|January 11, 2013
PubMed

Insights

Biliary atresia, a rare neonatal liver disease, causes severe cholestasis. Early surgical intervention via hepatoportoenterostomy improves outcomes and may delay liver transplantation.

Area of Science:

  • Neonatology
  • Pediatric Surgery
  • Hepatology

Background:

  • Biliary atresia is a rare neonatal disease causing severe cholestasis and biliary cirrhosis.
  • It is the most frequent surgical cause of cholestatic jaundice in neonates.
  • Untreated, it leads to death in early childhood.

Purpose of the Study:

  • To discuss modifications of the Kasai hepatoportoenterostomy for biliary atresia.
  • To emphasize the importance of early diagnosis and surgical intervention.
  • To highlight the role of liver transplantation in advanced cases.

Main Methods:

  • Review of surgical techniques for hepatoportoenterostomy (Kasai procedure).
  • Discussion of treatment sequence involving Kasai procedure and potential liver transplantation.
  • Emphasis on clinical signs: cholestatic jaundice, pale stools, hepatomegaly.

Main Results:

  • Early hepatoportoenterostomy can restore biliary flow and reduce liver damage.
  • Timely Kasai procedure can delay or obviate the need for liver transplantation.
  • Biliary atresia is the most common pediatric indication for liver transplantation.

Conclusions:

  • Early surgical intervention for biliary atresia is crucial for improving patient outcomes.
  • Systematic screening for biliary atresia is warranted due to its severity.
  • The Kasai procedure, when performed early, significantly impacts long-term prognosis.

Related Concept Videos